Mitsubishi Ufj Trust & Banking Corp Trimmed Medtronic Plc (MDT) Position by $4.40 Million

December 7, 2017 - By Michael Collier

Investors sentiment decreased to 0.9 in Q2 2017. Its down 0.06, from 0.96 in 2017Q1. It worsened, as 72 investors sold MDT shares while 449 reduced holdings. 99 funds opened positions while 370 raised stakes. 1.06 billion shares or 2.23% less from 1.08 billion shares in 2017Q1 were reported. Signature Fincl Mngmt Inc has invested 0.08% in Medtronic plc (NYSE:MDT). Eqis Management has 0.12% invested in Medtronic plc (NYSE:MDT) for 22,903 shares. Clark Estates holds 334,652 shares. Cardinal Management invested in 54,534 shares or 1.6% of the stock. Hightower Advsrs Limited Company reported 269,925 shares or 0.21% of all its holdings. Hilltop stated it has 0.11% of its portfolio in Medtronic plc (NYSE:MDT). Georgia-based Lakeview Cap Ltd Liability Com has invested 0.23% in Medtronic plc (NYSE:MDT). Suffolk Cap Mgmt Limited Liability Co invested 1.36% of its portfolio in Medtronic plc (NYSE:MDT). Genesee Valley Company invested in 0.63% or 16,835 shares. Evergreen Mgmt Ltd Liability Corp holds 37,612 shares or 0.54% of its portfolio. Ledyard Bankshares has 0.89% invested in Medtronic plc (NYSE:MDT) for 70,266 shares. 62,282 were accumulated by Amer Fincl Bank. Regentatlantic Cap Limited Com holds 8,494 shares or 0.07% of its portfolio. Boston Llc has invested 0.01% in Medtronic plc (NYSE:MDT). White Pine Capital Lc holds 0.1% or 2,836 shares in its portfolio.

Mitsubishi Ufj Trust & Banking Corp decreased its stake in Medtronic Plc (MDT) by 1.75% based on its latest 2017Q2 regulatory filing with the SEC. Mitsubishi Ufj Trust & Banking Corp sold 50,021 shares as the company’s stock rose 5.51% with the market. The institutional investor held 2.81M shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q2, valued at $249.25M, down from 2.86 million at the end of the previous reported quarter. Mitsubishi Ufj Trust & Banking Corp who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $109.05 billion market cap company. The stock decreased 1.14% or $0.93 during the last trading session, reaching $80.57. About 5.45 million shares traded. Medtronic plc (NYSE:MDT) has risen 4.04% since December 7, 2016 and is uptrending. It has underperformed by 12.66% the S&P500.

Mitsubishi Ufj Trust & Banking Corp, which manages about $51.75 billion US Long portfolio, upped its stake in Aramark (NYSE:ARMK) by 80,666 shares to 571,159 shares, valued at $23.41 million in 2017Q2, according to the filing. It also increased its holding in Anthem Inc. (NYSE:ANTM) by 17,841 shares in the quarter, for a total of 820,792 shares, and has risen its stake in Autohome Inc (NYSE:ATHM).

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 27 analysts covering Medtronic (NYSE:MDT), 17 have Buy rating, 0 Sell and 10 Hold. Therefore 63% are positive. Medtronic had 74 analyst reports since August 10, 2015 according to SRatingsIntel. The company was maintained on Monday, June 26 by Oppenheimer. The rating was maintained by SunTrust with “Buy” on Friday, November 17. The stock of Medtronic plc (NYSE:MDT) has “Buy” rating given on Thursday, June 2 by Deutsche Bank. Needham maintained Medtronic plc (NYSE:MDT) on Wednesday, November 23 with “Buy” rating. As per Friday, April 21, the company rating was maintained by Northland Capital. Needham maintained the shares of MDT in report on Tuesday, November 21 with “Buy” rating. As per Wednesday, June 1, the company rating was downgraded by BTIG Research. The firm has “Outperform” rating given on Monday, August 10 by Credit Suisse. The rating was maintained by Jefferies on Tuesday, November 21 with “Buy”. Needham maintained Medtronic plc (NYSE:MDT) rating on Wednesday, February 22. Needham has “Buy” rating and $91 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: